Statistics

Total Visits

Views
Analysis of sorafenib starting dose and outcomes from the European subset of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib SOR ) in > 1000 patients (pts)53

Select a period of time:

Number of views in the range

Views
Analysis of sorafenib starting dose and outcomes from the European subset of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib SOR ) in > 1000 patients (pts)39

Views

Views
February 20250
March 202516
April 20252
May 20250
June 20250
July 202520
August 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
Brazil9
United States8
United Kingdom3
Argentina1
Spain1
South Africa1
 

Top cities views

Views
Caucaia1
Council Bluffs1
Curitiba1
Dade City1
Guarulhos1
Moreno1
Morretes1
Mount Pleasant1
New Orleans1
Omaha1